FORT MYERS, Fla., February 3, 2020 — The American Oncology Network, LLC (AON) in-house specialty pharmacy has announced recent accreditation by URAC. The organization is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. By achieving this status, AON Pharmacy demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes. The AON specialty pharmacy, based in Fort Myers, Florida, works exclusively on behalf of more than 70 physicians in its growing network of community-based oncology practices to deliver oral cancer medications to their patients’ homes. Oral anti-cancer medication currently comprises 25% to 30% of the oncology treatments provided to patients nationwide.
“AON Pharmacy should be commended for meeting these rigorous national quality standards,” said AON CEO Brad Prechtl, MBA. “This accreditation represents our commitment to our physicians and their patients to providing the highest quality of services to ensure patient safety.”
For more about AON’s accreditation, see the full press release.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Bridging Care Gaps With a Systemwide Value-Based Care Strategy
March 29th 2025Mapping care management needs by defining patient populations and then stratifying them according to risk and their needs can help to spur the transformation of a siloed health care system into an integrated system that is able to better provide holistic, value-based care despite the many transitions that continue among hospital, primary, specialty, and community care environments.
Read More
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More